Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 242 of 640

Advanced search

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07773012: Efficacy of Bifidobacterium Animalis Subsp. Lactis in the Treatment of Indirect Hyperbilirubinemia in Term Neonates

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07772895: Pemefolacianine for IMI of Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07772661: Comaparative Effects of Bowen Technqiue With and Withour Extracorporeal Shock Wave in Patientys With Deep Gliteal Pain Syndrome.

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07772570: Multimodal Biomarkers in Coronary Artery Disease Pathogenesis: The Oxford Acute Myocardial Infarction Study (OXAMI Study)

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07772466: Atherosclerosis in Early Rheumatoid Arthritis Patients Using Atherogenic Index of the Plasma and Carotid Intima Media Thickness

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07770958: Circadian Disruption And Cardiovascular Risk In Young Adults With Hypertension

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07762703: Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07726888: Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07588698: Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07584356: A Study Comparing Shoulder Replacement Techniques For Patients With Shoulder Arthritis And An Intact Rotator Cuff

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07504458: Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07499674: Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07493304: Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07474558: SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07293143: Glycemic Effects of Meals - Repeatability Trial With Continuous Glucose Monitoring

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07224633: A Clinical In-Use Evaluation to Assess the Tolerability and Efficacy of a Moisturizer on Acne Prone Skin

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07203053: A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07115043: A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07042295: Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07029386: Effects of Transcranial Electrical Stimulation on Cognitive Impairment in CNS Inflammatory Demyelinating Diseases

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT07005362: Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT06860529: Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT06788678: A Randomized Controlled Trial of a Web-Based Moral Elevation Intervention for Veterans With PTSD

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT06683352: A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT06597734: A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT06465810: Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT06092346: A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT06042478: Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT05790239: MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT05527652: Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT05424783: MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT05377255: Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT04803084: Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT04339777: Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT03740165: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT03493425: Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT01896999: Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT00690196: Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 19Researchclinicaltrials.govTier 1 · Trial registry

NCT00424866: FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Genscript Biotech Corporation (HKG:1548) Released Earnings Last Week And Analysts Lifted Their Price Target To HK$24.74

simplywall.stOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Lotte India clarifies choco pie recall after Drug FDA action

The Times of IndiaOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

K-Bio to Unveil Next-Gen Cancer Therapies at ESMO 2026... Targeting Europe with ADCs and Bispecific Antibodies

finance.biggo.comOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Inside retatrutide’s black market, Eli Lilly’s 6 new lawsuits, and a brewing FDA battle

MDLinxOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

A Look at Takeda Pharmaceutical Co Ltd (TAK) After 3.9% Gain -- GF Value $14.36 vs Price $18.05

GuruFocusOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Houston tops emerging US biopharma hubs with Rice biotech efforts among factors cited

Rice UniversityOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (LEGN) RSU grant lifts interim CEO stake to 35,142 shares

Stock TitanOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Unpacking IRA-Driven Formulary Pressure | PharmExec

Pharmaceutical ExecutiveOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (NASDAQ: LEGN) targets 19.1M new stock awards

Stock TitanOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Bernstein Names Top Biotech Stock Pick: Vertex Leads After Rival Drug Fails

Investing.comOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

FDA issues draft guidance clarifying differences between ANDAs and 505(b)(2) applications

RAPSOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Fake drug racket busted near Bidadi; medicines worth ₹5 crore seized

The HinduOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Trump is taking credit for sharply declining drug prices. The reality is more complex

PBSOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Karnataka FDA Seizes ₹5 Crore Counterfeit Drugs

WhalesbookOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI?

The Motley FoolOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI?

The Globe and MailOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Fake Drugs Worth Rs 5 Crore Seized in Karnataka

ChennaionlineOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Amylyx stock surges after avexitide Phase 3 trial success

qz.comOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

FDA wants feedback on how to regulate generative AI in medicine

Radiology BusinessOriginal source

🌍Aug 19discoverynews.google.comTier 3 · Aggregated media

Karnataka FDA seizes spurious drugs worth Rs 5 crore from illegal facility

India TodayOriginal source

🌍Aug 19discoverynews.google.comTier 2 · Trade media

Real-world psilocybin data suggest need for close monitoring

STATOriginal source